Levetiracetam Amarox

Levetiracetam, the active ingredient in Levetiracetam Amarox, is an anticonvulsant presented as a intravenous solution for intravenous use. It treats partial seizures, generalized tonic‑clonic seizures and myoclonic seizures in patients requiring acute seizure control.

GNH USA supplies Levetiracetam Amarox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic medication used to manage seizure disorders.

Partial seizures: reduces frequency and severity of focal onset seizures. Generalized tonic‑clonic seizures: helps control convulsive seizures affecting both hemispheres. Myoclonic seizures: decreases sudden muscle jerks associated with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: sensation of lightheadedness or unsteadiness. - Fatigue: feeling unusually tired or weak. - Headache: mild to moderate cranial pain. - Irritability: increased mood lability or agitation.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction with blistering and mucosal involvement. - Severe hypersensitivity: rash, fever, eosinophilia, and potential organ involvement. - Suicidal thoughts: emergence of depressive symptoms or suicidal ideation.

When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure safe use.

Renal impairment: adjust dose based on creatinine clearance. Hepatic dysfunction: monitor liver enzymes and consider dose modification. Psychiatric history: observe for mood changes or depression. Concomitant CNS depressants: assess additive sedation risk. Pregnancy: evaluate risk‑benefit as safety data are limited. Store at ambient temperature: keep in original container, protect from moisture and light.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: can lower levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Phenytoin: may modestly decrease levetiracetam exposure. - Valproic acid: potential for increased adverse effects. - Oral contraceptives: possible reduction in contraceptive effectiveness.